Malaria and onchocerciasis: On HLA and related matters

Parasitology Today

Volumn 12, Issue 5, 1996, Pages 179-186

  Meyer, G G ^a   Kremsner, P G ^a  

^a Institut fur Tropenmedizin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA D ANTIGEN;

HLA SYSTEM; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; IMMUNITY; MALARIA; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PLASMODIUM FALCIPARUM; REVIEW;

EID: 0342538567     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-4758(96)10011-9     Document Type: Review

References (83)

1. Weidanz, W.P. and Long, C.A. (1988) The role of T cells in immunity to malaria. Prog. Allery 41, 215-253
2. Troye-Blomberg, M. (1994) Human T-cell responses to blood stage antigens in Plasmodium falciparum malaria. Immunol. Lett. 41, 103-107
3. Gallin, M. et al. (1988) Cell-mediated immune response in human infection with Onchocerca volvulus. J. Immunol. 140, 1999-2007
4. Ward, D.J. et al. (1988) Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals. J. Infect. Dis. 157, 536-543
5. King, C.L. and Nutman, T.B. (1991) in Immunoparasitology Today (Ash, C. and Gallagher, R.B., eds), pp A54-A58, Elsevier Trend Journals, Cambridge
6. Bjorkmann, P.J. et al. (1987) The foreign antigen binding site and T cell recognition of class I histocompatibility antigens. Nature 329, 512-516
7. Brown, J.H. et al. (1993) Three dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364, 33-39
8. Amiel, J.L. (1967) in Histocompatibility Testing 1967 (Curtoni, E.S., Mattiuz, P.L. and Tosi, R.M., eds), pp 79-80, Munksgaard
9. Brewerton, D.A. et al. (1973) Ankylosing spondylitis and HLA-A27. Lancet i, 904-907
10. Schlosstein, L. et al. (1973) High association of a HLA antigen, w27, with ankylosing spondylitis. N. Engl. J. Med. 288, 704-706
11. Tiwari, J.L. and Terasaki, P.I. (1985) HLA and Disease Associations. Springer
12. Hill, A.V.S. et al. (1991) Common West African HLA antigens are associated with protection from severe malaria. Nature 352, 595-600
13. Meyer, C.G. et al. (1994) HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection. Proc. Natl Acad. Sci. USA 91, 7515-7519
14. Wassom, D.L. et al. (1984) H-2 controlled, dose-dependent suppression of the response that expels adult Trichinella spiralis from the small intestine of mice. Immunology 53, 811-818
15. WHO (1994) World malaria situation in 1992. Weekly Epidemiol. Rec. 69, 309-316
16. Eling, W.M.C. and Kremsner, P.C. (1994) Cytokines in malaria, pathology and protection. Biotherapy 7, 211-221
17. Grau, G.E. et al. (1989) Tumor necrosis factor and disease severity in children with Plasmodium falciparum malaria. N. Engl. J. Med. 320, 1586-1591
18. McGuire, W. et al. (1994) Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371, 508-510
19. Grau, G.E. et al. (1987) Tumor necrosis factor/cachectin as an essential mediator in murine cerebral malaria. Science 237, 1210-1212
20. Kremsner, P.G. et al. (1991) Pentoxifylline prevents murine cerebral malaria. J. Infect. Dis. 164, 605-608
21. Kremsner, P.G. et al. (1995) Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production. Am. J. Trop. Med. Hyg. 53, 532-538
22. Clark, I.A. and Hunt, N.H. (1983) Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria. Infect. Immun. 39, 1-6
23. Senaldi, G., Kremsner, P.G. and Grau, G.E. (1992) Nitric oxide and cerebral malaria. Lancet 340, 1554-1555
24. Rockett, K.A. et al. (1991) Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect. Immun. 59, 3280-3283
25. Kremsner, P.G. et al. (1992) Interferon-γ induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine. Eur. J. Immunol. 22, 2873-2878
26. Cot, S. et al. (1994) Nitric oxide in cerebral malaria. J. Infect. Dis. 169, 1417-1418
27. Thumwood, C.M. et al. (1989) Antioxidants can prevent cerebral malaria in Plasmodium berghei-infected mice. Br. J. Exp. Pathol. 70, 293-303
28. Kremsner, P.G. et al. (1990) Immune response during and after Plasmodium falciparum infection. J. Infect. Dis. 161, 1025-1028
29. Kremsner, P.G. and Bienzle, U. (1989) Soluble CD8 antigen in Plasmodium falciparum malaria. J. Infect. Dis. 160, 357-358
30. Hoffmann, S.L. et al. (1989) Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science 244, 1078-1081
31. Gupta, S. et al. (1994) Parasite virulence and disease patterns in Plasmodium falciparum malaria. Proc. Natl Acad. Sci. USA 91, 3715-3719
32. Quakyi, I.A. et al. (1994) Analysis of human T cell clones specific for conserved peptide sequences within malaria proteins. J. Immunol. 153, 2082-2092
33. Wirtz, R.A. et al. (1987) Plamodium berghei: cloning of the circumsporozoite protein gene. Exp. Parasitol. 63, 166-172
34. Hoffman, S.L. et al. (1989) Immune response gene regulation of immunity to Plasmodium berghei sporozoites and circumsporozoite vaccines. J. Immunol. 142, 3581-3584
35. Miller, L.H. (1994) Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans. Proc. Natl Acad. Sci. USA 91, 2415-2419
36. Hill, A.V.S. et al. (1992) Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360, 434-439
37. Zhu, J. and Hollingdale, M. (1991) Structure of Plasmodium falciparum liver stage antigen 1. mol. Biochem. Parasitol. 48, 223-226
38. Malik, A. et al. (1991) Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Proc. Natl Acad. Sci. USA 88, 3300-3304
39. Alonso, P.E. et al. (1994) Randomized trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 344, 1175-1181
40. D'Allesandro, U. et al. (1995) Efficacy trial of malaria vaccine Spf66 in Gambian infants. Lancet 346, 462-467
41. Riley, E.M. et al. (1992) MHC and malaria: the relationship between HLA class II alleles and immune responses to Plasmodium falciparum. Intern. Immunol. 4, 1055-1063
42. Bennet, S. et al. (1993) Human leucocyte antigen (HLA) and malaria morbidity in a Gambian community. Trans. R. Soc. Trop. Med. Hyg. 87, 286-287
43. Riley, E.M. et al. (1990) Cellular and humoral responses to Plasmodium falciparum gametocyte antigens in malaria-immune individuals: limited respopnse to the 48/45 kD surface antigen does not appear to be due to MHC restriction. J. Immunol. 144, 4810-4816
44. Riley, E.M. et al. (1994) Human antibody responses to Pfs 230, a sexual stage-specific surface antigen of Plasmodium falciparum: non-responsiveness is a stable phenotype but does not appear to be genetically regulated. Parasite Immunol. 16, 55-62
45. WHO (1987) Expert Committee on onchocerciasis. Third Report. WHO Tech. Rep. Ser. 752
46. Tsang, V.C. et al. (1991) Guatemalan human onchocerciasis. I. Systematic analysis of patient populations, nodular antigens, and specific isotypic reactions. J. Immunol. 146, 3993-4000
47. Boyer, A.E. (1991) Guatemalan human onchocerciasis. II. Evidence for IgG3 involvement in acquired immunity to Onchocerca volvulus and identification of possible immune-associated antigens. J. Immunol. 146, 4001-1010
48. Elson, L. et al. (1994) Immunity to onchocerciasis: identification of a putative immune population in a hyperendemic area of Ecuador. J. Infect. Dis. 169, 588-594
49. Elson, L.H. et al. (1995) Immunity to onchocerciasis: Putative immune persons produce a Th1-like response to Onchocerca volvulus. J. Infect. Dis. 171, 652-658
50. Greene, B.M. et al. (1985) Humoral and cellular immune responses to Onchocerca volvulus infection in humans. Rev. Infect. Dis. 7, 789-795
51. Ottesen, E.A. (1985) Immediate hypersensitivity responses in the immunopathogenesis of human onchocerciasis. Rev. Infect. Dis. 7, 796-801
52. Ottesen, E.A. (1992) Infection and disease in lymphatic filariasis: an immunological perspective. Parasitology 104, S71-S79
53. Murdoch, M.E. (1992) The skin and the immune response in onchocerciasis. Trop. Doc. 22, 44-55
54. Kazura, J.W., Nutman, T.B. and Rickard, M.D. (1993) in Immunology and Molecular Biology of Parasitic Infections. (Warren, K.S., ed.), pp 473-495, Blackwell Scientific
55. Ottesen, E.A. (1995) Immune responsiveness and the pathogenesis of human onchocerciasis. J. Infect. Dis. 171, 659-671
56. Greene, B.M., Fanning, M.M. and Ellner J.J. (1983) Non-specific suppression of antigen-induced lymphocyte blastogenesis in Onchocerca volvulus infection in man. Clin. Exp. Immunol. 52, 259-265
57. Elkhalifa, M.Y. et al. (1991) Suppression of human lymphocyte responses to specific and non-specific stimuli in human onchocerciasis. Clin. Exp. Immunol. 86, 433-439
58. Soboslay, P.T. et al. (1992) Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment. Clin. Exp. Immunol. 89, 407-413
59. Merino, F. and Brand, A. (1977) Immunological studies in onchocerciasis patients. Trop. Med. Parasitol. 28, 229-234
60. Ndiaye, A.B. et al. (1987) Les facteurs humoraux et cellulaires de l'immunité au cours de l'onchocercose (résultats d'études effectuées aus Senegal). Bull. Soc. Pathol. Exot. 80, 230-241
61. Brattig N. et al. (1994) Strong immunoglobulin G isotypic antibody response in Sowdah type onchocerciasis. J. Infect. Dis. 170, 955-961
62. Dafa'Alla, T.H. et al. (1992) The profile of IgG and IgG sub-classes of onchocerciasis patients. Clin. Exp. Immunol. 88, 258-263
63. Ottesen, E.A. (1987) Description, mechanisms and control of reactions to treatment in the human filariases. Ciba Foundation Symposium 127, 265-283
64. Soboslay, P.T. et al. (1994) Ivermectin-facilitated immunity in onchocerciasis: activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection. Clin. Exp. Immunol. 96, 238-244
65. Thambiah, G. et al. (1992) Identification and characterization of a parasite antigen in the circulating immune complexes of Onchocerca volvulus-infected patients. Trop. Med. Parasitol. 48, 271-276
66. Nutman, T.B., Kumaraswami, V. and Ottesen, E.A. (1987) Parasite specific anergy in human filariasis: insights after analysis of parasite antigen-driven lymphokine production. J. Clin. Invest. 79, 1516-1523
67. Kilian, H.D. and Nielson, G. (1989) Cell-mediated and humoral immune response to tetanus vaccinations in onchocerciasis patients. Trop. Med. Parasitol. 40, 445-453
68. Wassom, D.L., Krco, C.J. and David, C.S. (1987) I-E expression and susceptibility to parasite infection. Immunol. Today 8, 39-43
69. Kennedy, M.W., Fraser, E.M. and Christie, J.F. (1991) MHC class II (I-A) region control of the IgE antibody repertoire to the ABA-1 allergen of the nematode Ascaris. Immunology 71, 577-579
70. Behnke, J.M. and Wahid, F. (1991) Immunological relationships during primary infection with Heligmosomoides polygyrus (Nematospiroides dubius): H-2 linked genes determine worm survival. Parasitology 103, 157-164
71. Brattig, N.W. et al. (1986) Differences in the distribution of HLA antigens in localized and generalized form of onchocerciasis. Trop. Med. Parasitol. 37, 271-275
72. Meyer, C.G., Schnittger, L. and May, J. Met-11 of HLA class II DPα1 first domain associated with onchocerciasis. Exp. Clin. Immunogenet. (in press)
73. Benacerraf, B. (1991) Role of MHC gene products in immune regulation. Science 212, 1229-1238
74. Murray, J.S. et al. (1992) Major histocompatibility complex (MHC) control of CD4 T cell subset activation, II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype. Eur. J. Immunol. 22, 559-565
75. Hirayama, K. et al. (1987) HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans. Nature 327, 426-430
76. Sasazuki, T. et al. (1989) HLA-linked immune suppression in humans. Immunology Suppl. 2, 21-24
77. + T cells is receptor dependent and HLA-DQ restricted. Proc. Natl Acad. Sci. USA 88, 2598-2602
78. Bloom, B.R., Salgame, P. and Diamond, B. (1992) Revisiting and revising suppressor T cells. Immunol. Today 13, 131-136
79. Ottenhoff, T.H.M. et al. (1986) Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Nature 322, 462-464
80. Nutman, T.B. et al. (1984) Parasite antigen-specific human T cell lines and clones. Major histocompatibility complex restriction and B cell helper function. J. Clin. Invest. 73, 1754-1762
81. Altmann, D.M., Sansom, D. and Marsh, S.G.E. (1991) What is the basis for HLA-DQ association with autoimmune disease? Immunol. Today 12, 267-270
82. Ishikura, H., Ishikawa, N. and Aizawa, M. (1987) Differential expression of HLA class II antigens in the human thymus. Relative paucity of HLA-DQ antigens in the thymic medulla. Transplantation 44, 314-317
83. Gallin, M. et al. (1995) Human autoantibody to defensin: disease association with hyperreactive onchocerciasis (Sowda). J. Exp. Med. 182, 41-47